Leukoscan recommended for European approval
This article was originally published in Clinica
Executive Summary
Immunomedics' radiolabelled antibody, Leukoscan, has been recommended for approval to the European Agency for the Evaluation of Medicinal Products (see Clinica No 666, p 18). Leukoscan is for detecting and diagnosing osteomyelitis in long bones and, in particular, in diabetics.